Business Wire24d
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.
PE Hub20d
PE-backed Cosette Pharmaceuticals to acquire Mayne Pharma for $430m
Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.
The Australian Financial Review23d
US pharma giant Cosette makes $672m bid for Mayne Pharma
Mayne Pharma sells products in Australia and the US for birth control and menopause treatments, including its Nextstellis contraceptive pill. Shutterstock Mayne’s shareholders include Viburnum ...